The comparison of the effects of rosuvastatin 5mg and pitavastatin 2mg on hypertensive patients

The comparison of the effects of rosuvastatin 5mg and pitavastatin 2mg on hypertensive patients - The comparison of the effects of rosuvastatin 5mg and pitavastatin 2mg on hypertensive patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009241

Enrollment

100

Registered

2012-11-01

Start date

2012-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyslipidemia with hypertension

Interventions

drug therapy rosuvastatin drug therapy pitavastatin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: hypertension LDL-C>140

Exclusion criteria

Exclusion criteria: Old myocardial infarction, DM, TG>400

Design outcomes

Primary

Measure	Time frame
LDL-C	—

Countries

Japan

Contacts

Public ContactHiroshi Hasegawa

Chiba University Department of Cardiovascular Medicine

hasegawa-chiba@umin.ac.jp0432227171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026